A detailed history of Oppenheimer Asset Management Inc. transactions in Certara, Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 197,724 shares of CERT stock, worth $2.25 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
197,724
Previous 135,744 45.66%
Holding current value
$2.25 Million
Previous $2.43 Million 12.81%
% of portfolio
0.04%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$13.36 - $18.94 $828,052 - $1.17 Million
61,980 Added 45.66%
197,724 $2.74 Million
Q1 2024

May 06, 2024

SELL
$15.65 - $19.45 $33,788 - $41,992
-2,159 Reduced 1.57%
135,744 $2.43 Million
Q4 2023

Feb 13, 2024

BUY
$12.12 - $18.19 $58,248 - $87,421
4,806 Added 3.61%
137,903 $2.43 Million
Q3 2023

Nov 07, 2023

BUY
$13.9 - $19.58 $161,837 - $227,969
11,643 Added 9.59%
133,097 $1.94 Million
Q2 2023

Aug 02, 2023

SELL
$16.89 - $24.64 $1.5 Million - $2.19 Million
-88,910 Reduced 42.26%
121,454 $2.21 Million
Q1 2023

May 10, 2023

BUY
$15.9 - $24.72 $170,925 - $265,740
10,750 Added 5.39%
210,364 $5.07 Million
Q4 2022

Feb 06, 2023

SELL
$10.7 - $17.84 $187,892 - $313,270
-17,560 Reduced 8.09%
199,614 $3.21 Million
Q3 2022

Nov 14, 2022

SELL
$12.84 - $24.13 $56,175 - $105,568
-4,375 Reduced 1.97%
217,174 $2.88 Million
Q2 2022

Aug 08, 2022

SELL
$16.75 - $22.54 $164,652 - $221,568
-9,830 Reduced 4.25%
221,549 $4.75 Million
Q1 2022

May 12, 2022

BUY
$17.89 - $28.73 $289,227 - $464,477
16,167 Added 7.51%
231,379 $4.97 Million
Q4 2021

Feb 02, 2022

BUY
$26.1 - $45.21 $2.98 Million - $5.17 Million
114,353 Added 113.38%
215,212 $6.12 Million
Q3 2021

Nov 12, 2021

BUY
$24.46 - $38.41 $2.47 Million - $3.87 Million
100,859 New
100,859 $3.34 Million

Others Institutions Holding CERT

About Certara, Inc.


  • Ticker CERT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 159,899,008
  • Market Cap $1.82B
  • Description
  • Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...
More about CERT
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.